What Helex does
Founded in 2021, Helex is a biotechnology startup that focuses on genome engineering and synthetic biology solutions. The company initially centred on developing advanced CRISPR technologies to modify genes with higher precision. It has since expanded its offerings, launching a series of proprietary tools aimed at enhancing gene editing accuracy and reducing off-target effects. Helex has forged strategic partnerships with leading research institutions to facilitate the integration of its technologies into various applications.
Who runs it
Funding and finances
Why this matters to you: funding stage is a rough proxy for how long the runway is and how much structure to expect. It is not a promise, and a profitable bootstrapped company can be the safer bet.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about Helex yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.